David Budd, chief executive of Genedrive PLC (LON:GDR), tells Proactive they've begun commercial sales and shipments of their Genedrive HCV ID Kit, a qualitative molecular assay for HCV and Genedrive platform into the EMEA region - with an initial focus on Africa.
The products have been shipped to their distributor, Sysmex Corporation, a world leader in clinical laboratory systemisation and solutions, and are now destined for use in various initial target countries.
Budd adds that first commercial sales and shipments of the HCV ID kit and platform are expected to commence in the Asia Pacific region in the coming weeks.
Meet AusCann Group Holdings Ltd, Pacific American Coal Ltd, Kasbah Resources, Hazer Group Ltd and Kazia Therapeutics Ltd at our event, Sydney, 19 March 2018.Register here >>